Delirium in the Neonate. Clin Perinatol 2022 Mar;49(1):1-14
Date
02/26/2022Pubmed ID
35209993DOI
10.1016/j.clp.2021.11.001Scopus ID
2-s2.0-85123347917 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Delirium is likely present in the neonatal intensive care unit and has been largely unrecognized. There are several risk factors for delirium including illness severity, neurosedative exposure, and environmental disruptions that put infants at risk for delirium. Regular use of scoring systems should be considered to improve delirium detection. When identified, initial steps in management should include resolving underlying causes and implementation of standard nonpharmacologic measures. Mounting pediatric evidence suggests that the atypical antipsychotics, as well as the α-2 agonists, may be additionally beneficial in treating delirium as well as improving the ability to wean off other neurosedative medications.
Author List
Adams SJ, Sprecher AAuthors
Samuel J. Adams MD Assistant Professor in the Neurology department at Medical College of WisconsinAlicia Sprecher MD Assistant Professor in the Pediatrics department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Antipsychotic AgentsBenzodiazepines
Child
Delirium
Humans
Infant
Infant, Newborn
Risperidone
